← Back to patent-cliff list
CAS 63257-26-1
4-amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)tetrahydropyrimidin-2(1H)-one
Codes: TETRA-002
Application context (from source-drug indications)
Non-small cell lung cancerTetrahydrouridineLung cancerTetrahydrouridineSickle cell diseaseTetrahydrouridineMyelodysplastic syndromeTetrahydrouridineAcute myeloid leukaemiaTetrahydrouridineMelanomaTetrahydrouridine
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Tetrahydrouridine | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
4-amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5,6-dihydropyrimidin-2(1H)-one→4-amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)tetrahydropyrimidin-2(1H)-one
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.